Top Secret however did exactly what they needed to do this year, producing a fine list of formulas, making some changes here and there, and successfully hitting the market in places they had not hit before
2M+ Patients Empowered by Lark 5.3% Average body weight lost in Lark's Diabetes Prevention Program* 10+ Years of experience in cardiometabolic condition support *Based on Lark program data for members meeting CDC qualification criteria
GLP-1 medications: Increase insulin secretion Decrease glucagon release Slow gastric emptying Reduce appetite and hunger signaling Act on receptors in the central nervous system GLP-1 receptor activity in the brain, pancreas, liver, stomach, and adipose tissue, reinforce that these medications affect more than weight alone
with the expanding assortment of branded GLP-1 medications, said Andrew Dudum, co-founder and CEO of Hims & Hers, in the announcement